ConMed posted 1Q18 arthroscopy/soft tissue repair revenue of US $108.9MM, +4.9% vs. 1Q17. Growth is attributed to new people and new products.
1Q18
1Q17
$ Change
% Change
Arthroscopy/Soft Tissue Repair
$108.9
$103.8
$5.1
4.9%
New people and new products continue to contribute to positive growth for ConMed. Early feedback is positive for systems shown at AAOS, such as the Hall MicroFree cordless power handpiece, the ExoShape soft tissue fasteners, new longer probes for hip arthroscopy with the Edge™ Bipolar Arthroscopic RF System, etc. The company continues to add products to its resection shaver line.
Leadership noted that new products for 2018 will launch in the second and third quarters, and also, orthopaedics remains a priority for R&D spend.
ConMed posted 1Q18 arthroscopy/soft tissue repair revenue of US $108.9MM, +4.9% vs. 1Q17. Growth is attributed to new people and new products.
Q18 1Q17 $ Change % Change
Arthroscopy/Soft Tissue Repair $108.9 ...
ConMed posted 1Q18 arthroscopy/soft tissue repair revenue of US $108.9MM, +4.9% vs. 1Q17. Growth is attributed to new people and new products.
1Q18
1Q17
$ Change
% Change
Arthroscopy/Soft Tissue Repair
$108.9
$103.8
$5.1
4.9%
New people and new products continue to contribute to positive growth for ConMed. Early feedback is positive for systems shown at AAOS, such as the Hall MicroFree cordless power handpiece, the ExoShape soft tissue fasteners, new longer probes for hip arthroscopy with the Edge™ Bipolar Arthroscopic RF System, etc. The company continues to add products to its resection shaver line.
Leadership noted that new products for 2018 will launch in the second and third quarters, and also, orthopaedics remains a priority for R&D spend.
Copy to clipboard 
